|
Accueil > Actualité
Pfizer: collaboration agreement with Summit Therapeutics
(CercleFinance.com) - Summit Therapeutics announced on Monday that it will partner with Pfizer in clinical trials combining its ivonescimab antibody with several antibody conjugates developed by the US healthcare giant.
The Florida-based pharmaceutical group says the trials, due to start mid-year, will focus on the treatment of several solid tumors. Summit and Pfizer will retain intellectual property rights to the products to be tested. Summit expects to provide further details on the studies in the near future. Copyright (c) 2025 CercleFinance.com. All rights reserved. |
10/04/2025 18:30
Argansigne un bail BEFA pour un nouvel entrepôt 'Aut0nom' 10/04/2025 18:20 Eurazeoinvestit dans Ekoscan Integrity Group (EIG) 10/04/2025 18:10 Colascontrat de 100ME sur 7 ans pour la filiale canadienne 10/04/2025 16:50 GE HealthCarepartenariat avec Cincinnati Children's 10/04/2025 16:38 Fordle titre recule, Goldman Sachs passe à 'neutre' 10/04/2025 16:23 LNA SantéFlorac Investissements à plus de 5% des votes Tous les articles sociétés |
